Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Cyclin E dysregulation and chromosomal instability in endometrial cancer

Abstract

Deregulation of cyclin E, an activator of cyclin-dependent kinase 2 (Cdk2), has been associated with a broad spectrum of human malignancies. Yet the mechanism linking abnormal cyclin E expression to carcinogenesis is largely unknown. The gene encoding the F-box protein hCdc4, a key component of the molecular machinery that targets cyclin E for degradation, is frequently mutated in endometrial cancer, leading to deregulation of cyclin E expression. Here we show that hCDC4 gene mutation and hyperphosphorylation of cyclin E, a parameter that usually correlates with hCDC4 mutation, have a strong statistically significant association with polypoidy and aneuploidy in endometrial cancer. On the contrary, elevated expression of cyclin E by itself was not significantly correlated with polyploidy or aneuploidy when tumors of similar grade are evaluated. These data suggest that impairment of cell cycle regulated proteolysis of cyclin E may be linked to carcinogenesis by promoting genomic instability.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Blegen H, Will JS, Ghadimi BM, Nash HP, Zetterberg A, Auer G and Ried T . (2003). Anal. Cell. Pathol., 25, 103–114.

  • Böcking A, Striepecke S, Auer H and Füzesi L . (1994). Static DNA Cytometry. Biological Background, Technique and Diagnostic Interpretation. Wied GL, Bartels PH, Rosenthal DL and Schenck U (eds). Tutorials of Cytology: Chicago, IL, USA, pp. 107–128.

    Google Scholar 

  • Bortner DM and Rosenberg MP . (1997). Mol. Cell. Biol., 17, 453–459.

  • Clurman BE, Sheaff RJ, Thress K, Groudine M and Roberts JM . (1996). Genes Dev., 10, 1979–1990.

  • Coverley D, Laman H and Laskey RA . (2002). Nat. Cell. Biol., 4, 523–528.

  • Donnellan R and Chetty R . (1999). FASEB J., 13, 773–780.

  • Ekholm SV and Reed SI . (2000). Curr. Opin. Cell Biol., 12, 676–684.

  • Erlanson M and Landberg G . (1998). Cytometry, 32, 214–222.

  • Haas K, Johannes C, Geisen C, Schmidt T, Karsunky H, Blass-Kampmann S, Obe G and Moroy T . (1997). Oncogene, 15, 2615–2623.

  • Haroske G, Baak JP, Danielsen H, Giroud F, Gschwendtner A, Oberholzer M, Reith A, Spieler P and Bocking A . (2001). Anal. Cell. Pathol., 23, 89–95.

  • Keyomarsi K, Conte D, Toyofuku W and Fox MP . (1995). Oncogene, 11, 941–950.

  • Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW and Bacus SS . (2002). N. Engl. J. Med., 347, 1566–1575.

  • Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, Pere H, Tapper J, Tarkkanen M, Varis A, Wasenius VM, Wolf M and Zhu Y . (1999). Am. J. Pathol., 155, 683–694.

  • Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW and Elledge SJ . (2001). Science, 294, 173–177.

  • Lacey KR, Jackson PK and Stearns T . (1999). Proc. Natl. Acad. Sci. USA, 96, 2817–2822.

  • Mikuz G, Hofstaedter F and Delgado R . (1985). Anal. Quant. Cytol. Histol., 7, 343–346.

  • Moberg KH, Bell DW, Wahrer DC, Haber DA and Hariharan IK . (2001). Nature, 413, 311–316.

  • Reed SI . (1996). Biochim. Biophys. Acta, 1287, 151–153.

  • Reed SI . (1997). Cancer Surv., 29, 7–23.

  • Resnitzky D, Gossen M, Bujard H and Reed SI . (1994). Mol. Cell. Biol., 14, 1669–1679.

  • Spruck CH, Strohmaier H, Sangfelt O, Muller HM, Hubalek M, Muller-Holzner E, Marth C, Widschwendter M and Reed SI . (2002). Cancer Res., 62, 4535–4539.

  • Spruck CH, Won KA and Reed SI . (1999). Nature, 401, 297–300.

  • Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O and Reed SI . (2001). Nature, 413, 316–322.

  • Suzuki A, Fukushige S, Nagase S, Ohuchi N, Satomi S and Horii A . (1997). Hum. Genet., 100, 629–636.

  • Won KA and Reed SI . (1996). EMBO J., 15, 4182–4193.

Download references

Acknowledgements

This work was supported by a Grant from ‘Fonds zur Förderung der wissenschaftlichen Forschung’ P15995-B05, P16159-B05 and from ‘Jubiläumsfonds der Österreichischen Nationalbank’, Project # 9856, and by NIH Grant CA78343 to SIR.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin Widschwendter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hubalek, M., Widschwendter, A., Erdel, M. et al. Cyclin E dysregulation and chromosomal instability in endometrial cancer. Oncogene 23, 4187–4192 (2004). https://doi.org/10.1038/sj.onc.1207560

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207560

Keywords

This article is cited by

Search

Quick links